Ekaterina Kuznetsova

Dr. Ekaterina Kuznetsova


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
EBElena E. Baranova
Elena E. Baranova
OSOlesya Sagaydak
Olesya Sagaydak
AGAlexandra M. Galaktionova
Alexandra M. Galaktionova
EKEkaterina Kuznetsova
Ekaterina Kuznetsova
MKMadina T. Kaplanova
Madina T. Kaplanova
ESEkaterina N. Songolova
Ekaterina N. Songolova
Background: A fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. Firstly, in Russia according a new regulation it was possible to perform a widescale testing of pregnant women in chromosomal abnormality risk. The aim of the study—to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.Methods: Based on the first trimester combined prenatal screening results 12,700 pregnant women were classified as a high-risk (cut-off ≥ 1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results from intermediate-risk group were considered for invasive prenatal diagnostic.Results: 258 (2.0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (p < 0.05) were revealed for fetal fraction (FF) and both for some patient’s (body mass index and weight) and fetus’s (sex and high risk of aneuploidies) characteristics. NIPT showed as a high sensitivity as specificity for common trisomies and SCAs with an overall false positive rate 0.3%.Conclusions: NIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown a high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.

1 January 2021 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
AOA.S. Olenev
A.S. Olenev
EBE.E. Baranova
E.E. Baranova
OSO.V. Sagaydak
O.V. Sagaydak
EKEkaterina Kuznetsova
Ekaterina Kuznetsova
AGA.M. Galaktionova
A.M. Galaktionova
ESE.N. Songolova
E.N. Songolova

1 January 2021 in Russian Journal of Human Reproduction
Verified
Journal Article
Closed access
AOA.S. Olenev
A.S. Olenev
EBE.E. Baranova
E.E. Baranova
OSO.V. Sagaydak
O.V. Sagaydak
EKEkaterina Kuznetsova
Ekaterina Kuznetsova
AGA.M. Galaktionova
A.M. Galaktionova
ESE.N. Songolova
E.N. Songolova

25 April 2022 in Research Square
Verified
Preprint
Open access
PDF file
EBElena E Baranova
Elena E Baranova
OSOlesya V. Sagaydak
Olesya V. Sagaydak
AGAlexandra M. Galaktionova
Alexandra M. Galaktionova
EKEkaterina Kuznetsova
Ekaterina Kuznetsova
MKMadina T. Kaplanova
Madina T. Kaplanova
ESEkaterina N. Songolova
Ekaterina N. Songolova
BackgroundA fast adoption of a non–invasive prenatal testing (NIPT) in clinical practice is a global tendency last years. The aim of the study - to assess efficiency of using NIPT as a second-line first trimester screening test in Moscow.MethodsBased on the results of the first trimester combined prenatal screening 12700 pregnant women were classified as a high-risk (cut-off ≥1:100) and an intermediate-risk (cut-off 1:101 – 1:2500) groups followed by whole genome NIPT. Women from high-risk group and those who had positive NIPT results were considered for invasive prenatal diagnostic. Results258 (2,0%) samples with positive NIPT results were detected including 126 cases of trisomy 21 (T21), 40 cases of T18, 12 cases of T13, 41 cases of sex chromosome aneuploidies (SCAs) and 39 cases of rare autosomal aneuploidies (RAAs) and significant copy number variations (CNVs). Statistically significant associations (p<0.05) were revealed for fetal fraction (FF) and both for some patient’s (body mass index and weight) and fetus’s characteristics (sex and high risk of aneuploidies). NIPT showed high sensitivity and specificity for common trisomies and SCAs with an overall false positive rate 0.3%.ConclusionsNIPT demonstrated high sensitivity and specificity. As a second-line screening test it has shown high efficiency in detecting fetus chromosomal anomalies as well as it could potentially lower the number of invasive procedures in pregnant women.

25 July 2022 in Akusherstvo i ginekologiia
Verified
Journal Article
Closed access
KKKaplanova M.T. Kaplanova
Kaplanova M.T. Kaplanova
GGGalaktionova A.M. Galaktionova
Galaktionova A.M. Galaktionova
OSOlesya Sagaydak
Olesya Sagaydak
EKEkaterina Kuznetsova
Ekaterina Kuznetsova
BBBelenikin M.S. Belenikin
Belenikin M.S. Belenikin
SHSalekhard Salekhard District Clinical Hospital
Salekhard Salekhard District Clinical Hospital